SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Ligand (LGND) Breakout! -- Ignore unavailable to you. Want to Upgrade?

To: Henry Niman who wrote (22732)6/26/1998 12:50:00 PM
From: WTDEC  Read Replies (1) | Respond to of 32384
 
Henry, I'm glad to see at least one WS firm is awake. These are high business leverage type developments which are demonstrating the soundness of LGND's strategy and should get increasing attention from the Street. IMO, LGND's strategy of building a broad pipeline as rapidly as possible, even though they had to issue shares at a premium to do so, will prove to be extremely beneficial to stockholders.

Regards,

Walter


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News